ÖSSUR/OTTOBOCK
Össur and Ottobock, two of the world’s leading prosthetics innovators, will undertake a historic joint philanthropic effort to further development in the breakthrough field of mind-controlled prosthetics, it was announced today.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160125006380/en/
Fueled by the companies’ initial combined contribution of US$1 million, the Össur and Ottobock Research Trust Fund that has been established at the University of Iceland will award international grants for scientific research and innovative projects in the field of advanced neural control of prosthetic limbs.
“Neural-controlled prosthetics is one of the greatest clinical challenges in our field, and its potential to impact lives is so significant that both companies embraced the opportunity to marshal resources and help accelerate this critical technological development,” said Thorvaldur Ingvarsson, M.D., Ph.D., Executive Vice President of Research and Development of Össur.
“Neural-controlled prosthetics could transform the lives of thousands of people with limb loss throughout the world, and we look forward to supporting the ongoing exploration of the field through the creation of this new fund,” said Dr. Hans Dietl, Chief Technology Officer of Ottobock.
The first grants from the Össur and Ottobock Research Fund at the University of Iceland will be rewarded within one year. The fund will be governed by a four-person committee, comprised of two University of Iceland representatives and one representative from each company.
“We are gratified that our University has been chosen to play a pivotal role in furthering mind-controlled prosthetics technology,” said Dr. Jón Atli Benediktsson, Rector of the University of Iceland. According to Dr. Benediktsson, details regarding the Fund’s grant application process will be announced in the near future.
About Össur
Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of Prosthetic, Osteoarthritis and Injury Solutions. A recognized “Technology Pioneer,” Össur invests significantly in research and product development—its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com
About Ottobock
Around the world, the Ottobock name stands for high-quality and technologically outstanding products and services. The goal of helping to restore mobility for people - or protect what mobility they have - stands behind each and every Ottobock product. The conviction that quality of life is closely associated with a maximum of individual freedom and independence is a key concept that has been a major influence throughout the company’s history. Since its founding in Berlin in 1919, Ottobock has pursued a vision: to improve the mobility of people with disabilities through innovative products. In doing so, the company equates quality with “Quality for life”: the quality of life enjoyed by the people who use Ottobock products every day. www.ottobock.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160125006380/en/
Contact:
For ÖSSUR:
Laura Jackson, +1-714-745-9526
lauraminjackson@gmail.com
or
For
OTTOBOCK:
Rüdiger Herzog, +49 5527 848 1859
ruediger.herzog@ottobock.de
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Moody’s Agentic Solutions to Automate Complex Workflows and Speed Human Decision-Making16.9.2025 14:00:00 CEST | Press release
Moody’s today announced Agentic Solutions, a groundbreaking addition to its suite of AI-powered offerings designed to transform how organizations make decisions in complex, high-stakes environments. The new solutions empower organizations to act with greater speed, precision, and confidence than ever before, reshaping how risk is decoded, opportunities are identified, and decisions are made. “For over a century, our customers have looked to Moody’s for premium data, trusted insights, and cutting-edge solutions to help them make better, more informed decisions,” said Rob Fauber, President and CEO of Moody’s. “Agentic Solutions is a natural extension of our legacy of investment and innovation – anchored in the strength of our industry leading data-estate and the depth of our people’s analytical skills. By integrating agentic capabilities into the workflows of our customers, we are supercharging the speed and precision at which we can help our customers understand risk and unlock opportun
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran16.9.2025 14:00:00 CEST | Press release
VELA to operate the world’s first sailing cargo trimaran powered by 100 percent wind when at sea1 to sail between Europe and the U.S.Takeda to become the first biopharmaceutical company to ship its products on VELA’s wind-powered trimaran, starting a new era of sustainable shipping in pharma Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s first-of-its-kind sailing cargo trimaran. VELA designed and will operate a fleet of new generation sailing cargo vessels, powered 100 percent by wind when at sea. Purpose-built to handle pharmaceutical products, VELA will offer reliable, secure and ultra-low-emission sea freight shipping. The maiden voyage is planned for late 2026. VELA’s new wind-powered sea freight will offer a climate-conscious alternative to other transportation for the pharmaceutical industry – cutting use-relat
Franklin Templeton Forms Strategic Partnership with Copenhagen Infrastructure Partners, DigitalBridge, and Actis to Expand Infrastructure Solutions for Private Wealth16.9.2025 14:00:00 CEST | Press release
Franklin Templeton, a global investment leader with more than $1.6 trillion in assets under management, together with three leading institutional infrastructure investment firms: Actis, the Sustainable Infrastructure business of General Atlantic; Copenhagen Infrastructure Partners (“CIP”); and DigitalBridge, today announced a strategic partnership to deliver private infrastructure solutions to individual investors. This partnership seeks to provide private wealth clients with differentiated access to high-growth infrastructure opportunities, thematically focused on energy security, electrification, and digitalization, as well as sectors including data centers and hyperscaler development, renewable energy, fiber and towers, and digital power. “We are excited to partner with three leading firms: DigitalBridge, CIP, and Actis, in response to a compelling market demand for allocations to infrastructure,” said Jenny Johnson, President and CEO, Franklin Templeton. “The trends shaping the pri
Matrix Executions Unveils White-Label Equity Options Algos: True Customization for Broker-Dealers16.9.2025 13:45:00 CEST | Press release
Matrix Executions, a leader in options trading technology, announced its latest launch of its white-label equity options algorithmic trading solutions. This product empowers broker dealers with true customization and control, enabling them to offer a bespoke algo trading experience to their clients. The product leverages Matrix Executions’ advanced execution algo suite overlayed with the Matrix QRX ATS for an all-in-one answer to execution customization. In today's dynamic market, a one-size-fits-all approach no longer works. Matrix Executions’ offering provides broker dealers with the ability to define, configure, and deploy option algorithms with varying levels of precision. This isn't just a re-skinned product but a foundation for dynamic innovation. The Matrix white-label solution provides extensive bespoke parameter configurations and true customization. Their robust strategy configuration library allows broker-dealers to fine-tune specific variables to optimize performance for di
Tecnotree Named a Visionary in the 2025 Gartner® Magic Quadrant™ for AI in CSP Customer and Business Operations16.9.2025 13:38:00 CEST | Press release
Tecnotree, a global leader in AI, 5G, and cloud-native digital platforms and services has been recognized as a Visionary in the 2025 Gartner® Magic Quadrant™ for AI in CSP Customer and Business Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916788293/en/ Tecnotree Named a Visionary in the 2025 Gartner® Magic Quadrant™ for AI in CSP Customer and Business Operations We feel this underscores the company’s ability to deliver AI-powered, cloud-native platforms that enable communications service providers (CSPs) and enterprises worldwide to accelerate digital transformation, monetize networks, and deliver hyper-personalized customer experiences. The Gartner report, authored by analysts Pulkit Pandey, Amresh Nandan, Will Rice, and Mounish Rai, evaluates leading AI vendors for CSP customer and business operations. According to Gartner, AI in CSP customer and business operations helps CSPs utilize AI/ML to generate ins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom